Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Report
MX:VRTX Q2 2024 EPS Results
- Actual EPS
- -MXN 241.10
- Consensus EPS
- -MXN 218.48
- Beat/Miss
- Missed by -MXN 22.63
- One Year Ago EPS
- MXN 73.10
MX:VRTX Q2 2024 Revenue Results
- Actual Revenue
- MXN 49.51B
- Expected Revenue
- MXN 50.06B
- Beat/Miss
- Missed by -MXN 544.20M
- YoY Revenue Growth
- +6.02%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/01/2024
- Time
- After Close
- Conference Call
- Thursday, August 1, 2024
MX:VRTX Upcoming Earnings
Vertex Pharmaceuticals's next earnings date is estimated for February 9, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
MX:VRTX Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:VRTX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 09, 2027 | 2026 (Q4) | ―- | 94.52 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | 90.52- | 90.2 | ― | |
| Aug 03, 2026 | 2026 (Q2) | 89.0988.89 | 84.94 | 4.65% (+3.95) | |
| May 04, 2026 | 2026 (Q1) | 79.7384.00 | 76.3 | 10.10% (+7.70) | |
| Feb 12, 2026 | 2025 (Q4) | 96.0594.52 | 74.79 | 26.38% (+19.73) | |
| Nov 03, 2025 | 2025 (Q3) | 85.9490.20 | 82.31 | 9.59% (+7.89) | |
| Aug 06, 2025 | 2025 (Q2) | 80.5884.94 | -241.1 | 135.23% (+326.04) | |
| May 05, 2025 | 2025 (Q1) | 81.1376.30 | 89.45 | -14.71% (-13.15) | |
| Feb 10, 2025 | 2024 (Q4) | 75.4774.79 | 78.93 | -5.24% (-4.13) | |
| Nov 04, 2024 | 2024 (Q3) | 76.6382.31 | 76.67 | 7.35% (+5.64) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
